After layoffs this fall, Mythic Therapeutics is winding down, putting all its assets up for sale and terminating its only ...

Philadelphia has lagged in biotech R&D jobs despite University of Pennsylvania scientists playing a leading role in ...

Jonas Salk quietly built the polio vaccine through rigorous, methodical work in Pittsburgh: treating patients, refinin ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will ...

The new EU Biotech Plan wants to keep research, clinical development, and manufacturing within the European Union. View on ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

OpenAI, Anthropic and Google have been on the prowl for specialized data to train their AI models, discussing deals with ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...